← SynDRA
VARLITINIB
SynDRA canonical compound SYN0030044 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | ERBB2 |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- EGFR MODULATOR
- ERBB2 MODULATOR
Cross-references
Synonyms
- AR-00334543
- ARRY-334543
- ARRY-543
- ASLAN-001
- ASLAN001
- ARRY 334543
- ARRY334543
- UNII-846Y8197W1
- 846Y8197W1
- (R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine
- Varlitinib [USAN:INN]
- Varlitinib (ARRY334543)
- Varlitinib free base
- Varlitinib (USAN/INN)
- MLS006011274
- GTPL7645
- SCHEMBL1384578
- CHEMBL2103842
- SYN1192
- MolPort-028-720-424
- EX-A1005
- 4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine
- ARRY 543
- varlitinibum
- AR 00334543
- AR00334543
- RefChem:901736
- DTXCID301509860
- Varlitinib [USAN]
- C22H19ClN6O2S
- MFCD20275099
- VARLITINIB [INN]
- VARLITINIB [WHO-DD]
- orb1685624
- SCHEMBL29353591
- SCHEMBL30148099
- CHEBI:231356
- GLXC-15581
- VIB27221
Look up VARLITINIB in the interactive SynDRA portal →